CWA
PROF

Carolina Wealth Advisors’s Profound Medical PROF Stock Holding History

Carolina Wealth Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$11.8K – 282
2025
Q2 		$11.8K Buy
+2,000
New +$10.6K 0.01% 142

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $183M AUM 38.9% 1-Year Est. Return

Carolina Wealth Advisors's PROF Position: Q3 2025 in Review

Carolina Wealth Advisors sold out of Profound Medical (PROF) in Q3 2025, closing a stake of 2,000 shares — an estimated $11.8K sold.

Carolina Wealth Advisors first reported a position in PROF in Q2 2025 and held it in 1 quarter. The position peaked at $11.8K in Q2 2025. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2025.

  • Carolina Wealth Advisors reported no remaining Profound Medical position as of Q3 2025 after selling out during the quarter.
  • Carolina Wealth Advisors sold 2,000 Profound Medical shares in Q3 2025, an estimated $11.8K.
  • Carolina Wealth Advisors first reported a position in Profound Medical in Q2 2025 and held it in 1 quarter.
  • Carolina Wealth Advisors's Profound Medical position peaked at $11.8K in Q2 2025.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2025.

Based on Carolina Wealth Advisors's 13F filing for Q3 2025, filed 7 Oct 2025.